Virios Therapeutics Announces Initial FDA Feedback on
-Virios’ IMC-1 Phase 3 Proposed Program is Considered Acceptable based on Initial FDA Feedback Pending Review of the Final Chronic Toxicology Program...
Source: globenewswire.com
Stay updated with breaking news from Considered Acceptable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Virios’ IMC-1 Phase 3 Proposed Program is Considered Acceptable based on Initial FDA Feedback Pending Review of the Final Chronic Toxicology Program...